Skip to content

Inspection Record

Invacare Corporation — FDA 483 Findings

US FDAInspected 2015-07-11Published 2024-01-17 11 findingsOther quality systemTraining and personnelMaterial and supplier controlComplaint and recall handlingRegulatory reporting and change controlValidation and qualification

Inspectors Richard K. Vogel · Andrea H. NorwoodThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

2Training and personnel

Personnel training is not documented.

3Training and personnel

Personnel do not have the necessary training to perform their jobs.

4Other quality system

Procedures for corrective and preventive action have not been adequately established.

5Other quality system

CORRECTIVE AND PREVENTATIVE ACTION ACTIVITIES AND/OR RESULTS HAVE NOT BEEN DOCUMENTED.

6Material and supplier control

Requirements that must be met by suppliers and contractors have not been adequately established.

7Complaint and recall handling

Complaints involving the possible failure ofa device and labeling to meet any ofits specifications were not evaluated where necessary.

8Other quality system

Corrective and preventive action activities and/or results have not been documented.

9Regulatory reporting and change control

An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of information that reasonably suggests that a marketed device may have caused or contributed to a death or serious injury.

10Validation and qualification

Design validation did not ensure the device conforms to defined user needs and intended uses.

11Regulatory reporting and change control

An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of information that reasonably suggests that a marketed device has malfunctioned and would be likely to cause or contribute to a death or serious injury if the malfunction were to recur.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2024-01-17. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Invacare Corporation company profile — full historyAll US FDA findings US FDA documents, 2024 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.